Greetings from the World Meeting on Sexual Medicine
Greetings from the World Meeting on Sexual Medicine
We greet you today from Lisbon, Portugal at the World Meeting on Sexual Medicine where leading experts from around the world come to present their findings on best practices in the treatment of sexual concerns. One of the exciting presentations from Dr Anita Clayton of the University of Virginia outlined a consensus evidence-based guideline on the diagnosis and treatment of women’s low sexual interest. Over 30% of woman have what is called low desire, and 10% of women have low desire and have distress about it – and these women can benefit from treatment.
The standard for treatment of low sexual desire in premenopausal women is medication and psychotherapy; in postmenopausal women the treatment may include medication, psychotherapy and hormone treatments. RCSW offers all of these services under one roof.
In addition to existing effective and safe treatments like Flibanserin (Addyi), there are many new medical treatment options in the pharmaceutical pipeline including Bremalanotide (modulating melanocortin, a neurotransmitter in the central nervous system), and a few new testosterone hormone treatment options.
Too often women who are distressed about their low desire suffer with it. These women avoid sexual encounters, avoid their partners or avoid dating, feel less like a woman, and have lower self-esteem. Other women drink alcohol to endure sex with their partner. Sexual desire problems can be caused by: depression (and its treatment), oral and long acting contraceptives, medications, and medical problems.
Finding the right balance between sexual excitement and sexual inhibition is the key to treating low desire: often women have too many inhibiting factors such as: anxiety, body image concerns, distracting thoughts, or biological inhibitors. And sometimes women have trouble tuning into what is exciting about sex– also for a wide range of reasons.
Treatment at RCSW is affordable and effective. Call us or email us for more information.
